Axiom, Zaiya Inc. deal

The companies will collaborate to identify small organic molecule antagonists of an intracellular signaling pathway implicated in allergy, asthma and inflammation. Axiom will receive research funding, and be eligible for milestones and royalties. Zaiya receives exclusive worldwide rights to lead candidates from the deal. ...